GE HealthCare TechnologiesSTU:L0T -0.39%72 Operating Margin % is 10.04% as of Mar. 2026, which is 25% below its 10-year median of 13.39. GuruFocus rates STU:L0T with a GF Score™ of 72/100 and a GF Value™ of €74.50 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, GE HealthCare Technologies ranks better than 72.3% on this metric.
GE HealthCare Technologies Inc operating margin has been in a 5-year decline. The average rate of decline per year is -4.1%.
The historical rank and industry rank for GE HealthCare Technologies's Operating Margin % or its related term are showing as below:
STU:L0T'
s Operating Margin % Range Over the Past 10 Years
Min: 12.45 Med: 13.39 Max: 15.89
Current: 12.63
STU:L0T's Operating Margin % is ranked better than 72.3% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.465
vs STU:L0T: 12.63
GE HealthCare Technologies (STU:L0T) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
GE HealthCare Technologies Operating Margin % Related Terms
GE HealthCare Technologies Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies Operating Margin % Chart
STU:L0T vs DXCM, STE, ZBH: Operating Margin % Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's Operating Margin % distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's Operating Margin % falls into.
GE HealthCare Technologies Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
GE HealthCare Technologies's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (STU:L0T) has a Operating Margin % of 10.04% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on GE HealthCare Technologies and its competitors. This is 25% below median its historical median of 13.39. Over the past decade, GE HealthCare Technologies' Operating Margin % has ranged from 12.45 to 15.89. According to the industry distribution chart, GE HealthCare Technologies ranks #226 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 27.7%.
Is GE HealthCare Technologies' Operating Margin % too high?
GE HealthCare Technologies' current Operating Margin % of 10.04% is 25% below median its 10-year median of 13.39. Over the past 10 years, this metric has ranged from a low of 12.45 to a high of 15.89. The Medical Devices & Instruments industry median Operating Margin % is 3.47. GE HealthCare Technologies' value of 10.04% is 189.8% above this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #226 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, GE HealthCare Technologies has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Operating Margin % compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #226 out of 816 companies for Operating Margin %. This puts GE HealthCare Technologies in the upper half of its industry. The industry median Operating Margin % is 3.47. GE HealthCare Technologies' value of 10.04% is 189.8% above this benchmark. Historically, GE HealthCare Technologies' own Operating Margin % has ranged from 12.45 to 15.89 over the past decade. While the company's 10-year median is 13.39 vs. the industry median of 3.47, GE HealthCare Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current Operating Margin % of 10.04% is 189.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current Operating Margin % is 10.04%, which is 25% below median its own 10-year median of 13.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (STU:L0T) is currently considered Modestly Undervalued. The stock's GF Value™ is €74.50, compared to a current price of €56.89 — trading 23.6% below its estimated fair value. The current Operating Margin % is 10.04%, which is 25% below median its 10-year median of 13.39 and 189.8% above the Medical Devices & Instruments industry median of 3.47. GE HealthCare Technologies' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For GE HealthCare Technologies (STU:L0T), the current Operating Margin % is 10.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (STU:L0T) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of €56.89 is trading 23.6% below its estimated GF Value™ of €74.50.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for STU:L0T:
Operating Margin %: 10.04% (25% below median its 10-year median of 13.39)
GF Value™: €74.50 vs. price of €56.89 (23.6% below fair value)
Industry Position: 189.8% above the Medical Devices & Instruments median (#226 of 816)
No single metric tells the full story. See the STU:L0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
72GF Score
Get the complete analysis for STU:L0T
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:L0T has been successfully added to your 
